oxprenolol has been researched along with albuterol in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Lockwood, RH; Sinkasaem, P | 1 |
| D'Ambrosio, D; Fabbri, L; Lang, R; Lucia, PD; Mazzeo, D; Panina-Bordignon, P; Self, C; Sinigaglia, F | 1 |
| Amini, A; Arvidsson, T; Lodén, H; Pettersson, C | 2 |
9 other study(ies) available for oxprenolol and albuterol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Selective metabolic effects of salbutamol in anesthetized cats.
Topics: Albuterol; Animals; Blood Glucose; Blood Pressure; Cats; Fatty Acids, Nonesterified; Female; Heart Rate; Isoproterenol; Lactates; Male; Oxprenolol; Potassium; Receptors, Adrenergic | 1976 |
Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-2 Receptor Antagonists; Adult; Albuterol; Bucladesine; Cell Differentiation; Colforsin; Cyclic AMP; Dendritic Cells; Dose-Response Relationship, Drug; Humans; Interferon-gamma; Interleukin-1; Interleukin-10; Interleukin-12; Interleukin-6; Lipopolysaccharides; Macrophages; Oxprenolol; RNA, Messenger; Th1 Cells; Th2 Cells; Tumor Necrosis Factor-alpha | 1997 |
Quantitative determination of salbutamol in tablets by multiple-injection capillary zone electrophoresis.
Topics: Albuterol; Electrophoresis, Capillary; Oxprenolol; Tablets | 2008 |
Principles for different modes of multiple-injection CZE.
Topics: Albuterol; Electrophoresis, Capillary; Imidazoles; Oxprenolol; Phenylpropanolamine; Reference Standards | 2008 |